Human Gene CYLD (ENST00000427738.8_8) from GENCODE V47lift37
  Description: CYLD lysine 63 deubiquitinase, transcript variant 4 (from RefSeq NM_001378743.1)
Gencode Transcript: ENST00000427738.8_8
Gencode Gene: ENSG00000083799.18_18
Transcript (Including UTRs)
   Position: hg19 chr16:50,775,997-50,835,846 Size: 59,850 Total Exon Count: 19 Strand: +
Coding Region
   Position: hg19 chr16:50,783,610-50,830,419 Size: 46,810 Coding Exon Count: 17 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesGeneReviewsModel Information
Methods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr16:50,775,997-50,835,846)mRNA (may differ from genome)Protein (956 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CYLD_HUMAN
DESCRIPTION: RecName: Full=Ubiquitin carboxyl-terminal hydrolase CYLD; EC=3.4.19.12; AltName: Full=Deubiquitinating enzyme CYLD; AltName: Full=Ubiquitin thioesterase CYLD; AltName: Full=Ubiquitin-specific-processing protease CYLD;
FUNCTION: Protease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Has endodeubiquitinase activity. Plays an important role in the regulation of pathways leading to NF-kappa-B activation. Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation. Negative regulator of Wnt signaling. Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules. Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis. Required for normal cell cycle progress and normal cytokinesis. Inhibits nuclear translocation of NF-kappa-B. Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation. Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells. Negatively regulates TNFRSF11A signaling and osteoclastogenesis (By similarity).
CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C- terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
ENZYME REGULATION: Inhibited by phosphorylation at serine residues.
SUBUNIT: Interacts (via CAP-Gly domain) with IKBKG/NEMO (via proline-rich C-terminal region). Interacts with TRAF2 and TRIP. Interacts with PLK1, DVL1, DVL3, MAVS, TBK1, IKKE and DDX58. Interacts (via CAP-Gly domain) with microtubules. Interacts with HDAC6 and BCL3. Interacts with SQSTM1 and MAP3K7. Identified in a complex with TRAF6 and SQSTM1 (By similarity).
SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region. Cytoplasm, cytoskeleton. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Note=Detected at the microtubule cytoskeleton during interphase. Detected at the midbody during telophase.
TISSUE SPECIFICITY: Detected in fetal brain, testis, and skeletal muscle, and at a lower level in adult brain, leukocytes, liver, heart, kidney, spleen, ovary and lung. Isoform 2 is found in all tissues except kidney.
PTM: Phosphorylated on several serine residues by IKKA and/or IKKB in response to immune stimuli. Phosphorylation requires IKBKG. Phosphorylation abolishes TRAF2 deubiquitination, interferes with the activation of Jun kinases, and strongly reduces CD40-dependent gene activation by NF-kappa-B.
DISEASE: Defects in CYLD are the cause of familial cylindromatosis (FCYL) [MIM:132700]; also known as Ancell-Spiegler cylindromas or turban tumor syndrome or dermal eccrine cylindromatosis. CYLD is an autosomal dominant and highly tumor type-specific disorder. The tumors (known as cylindromas because of their characteristic microscopic architecture) are believed to arise from or recapitulate the appearance of the eccrine or apocrine cells of the skin that secrete sweat and scent respectively. Cylindromas arise predominantly in hairy parts of the body with approximately 90% on the head and neck. The development of a confluent mass which may ulcerate or become infected has led to the designation 'turban tumor syndrome'. The skin tumors show differentiation in the direction of hair structures, hence the synonym trichoepithelioma.
DISEASE: Defects in CYLD are the cause of multiple familial trichoepithelioma type 1 (MFT1) [MIM:601606]; also known as epithelioma adenoides cysticum of Brooke (EAC) or hereditary multiple benign cystic epithelioma or Brooke-Fordyce trichoepitheliomas. MFT1 is an autosomal dominant dermatosis characterized by the presence of many skin tumors predominantly on the face. Since histologic examination shows dermal aggregates of basaloid cells with connection to or differentiation toward hair follicles, this disorder has been thought to represent a benign hamartoma of the pilosebaceous apparatus. Trichoepitheliomas can degenerate into basal cell carcinoma.
DISEASE: Defects in CYLD are the cause of Brooke-Spiegler syndrome (BRSS) [MIM:605041]. BRSS is an autosomal dominant disorder characterized by the appearance of multiple skin appendage tumors such as cylindroma, trichoepithelioma, and spiradenoma. These tumors are typically located in the head and neck region, appear in early adulthood, and gradually increase in size and number throughout life.
SIMILARITY: Belongs to the peptidase C67 family.
SIMILARITY: Contains 3 CAP-Gly domains.
SEQUENCE CAUTION: Sequence=AAF29029.1; Type=Frameshift; Positions=776, 808, 932; Sequence=BAA74872.2; Type=Erroneous initiation; Note=Translation N-terminally shortened;

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: CYLD
Diseases sorted by gene-association score: cylindromatosis, familial* (1381), brooke-spiegler syndrome* (1362), trichoepithelioma, multiple familial, 1* (1300), multiple familial trichoepithelioma* (801), salivary gland adenoid cystic carcinoma (21), spiradenoma (18), apocrine sweat gland neoplasm (17), anus basaloid carcinoma (16), epidermal appendage tumor (16), basal cell carcinoma (10), integumentary system benign neoplasm (7), regular astigmatism (6), visual agnosia (5)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 19.10 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 369.53 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -65.30242-0.270 Picture PostScript Text
3' UTR -1517.005427-0.280 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000938 - CAP-Gly_domain
IPR018200 - Pept_C19ubi-hydrolase_C_CS
IPR001394 - Peptidase_C19

Pfam Domains:
PF00443 - Ubiquitin carboxyl-terminal hydrolase
PF01302 - CAP-Gly domain
PF16607 - Phosphorylation region of CYLD, unstructured

SCOP Domains:
74924 - Cap-Gly domain
54452 - MHC antigen-recognition domain
54001 - Cysteine proteinases
57845 - B-box zinc-binding domain
57903 - FYVE/PHD zinc finger

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1IXD - NMR MuPIT 1WHL - NMR MuPIT 1WHM - NMR MuPIT 2VHF - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q9NQC7
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details Gene DetailsGene Details 
Gene SorterGene Sorter Gene SorterGene Sorter 
 RGD  WormBase 
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004843 thiol-dependent ubiquitin-specific protease activity
GO:0005515 protein binding
GO:0008233 peptidase activity
GO:0008234 cysteine-type peptidase activity
GO:0008270 zinc ion binding
GO:0016787 hydrolase activity
GO:0019901 protein kinase binding
GO:0036459 thiol-dependent ubiquitinyl hydrolase activity
GO:0046872 metal ion binding
GO:0061578 Lys63-specific deubiquitinase activity
GO:0070064 proline-rich region binding
GO:1990380 Lys48-specific deubiquitinase activity
GO:0003735 structural constituent of ribosome

Biological Process:
GO:0002376 immune system process
GO:0006508 proteolysis
GO:0006511 ubiquitin-dependent protein catabolic process
GO:0007049 cell cycle
GO:0007346 regulation of mitotic cell cycle
GO:0010803 regulation of tumor necrosis factor-mediated signaling pathway
GO:0016055 Wnt signaling pathway
GO:0016579 protein deubiquitination
GO:0032088 negative regulation of NF-kappaB transcription factor activity
GO:0032480 negative regulation of type I interferon production
GO:0043369 CD4-positive or CD8-positive, alpha-beta T cell lineage commitment
GO:0043393 regulation of protein binding
GO:0045087 innate immune response
GO:0045577 regulation of B cell differentiation
GO:0045581 negative regulation of T cell differentiation
GO:0045582 positive regulation of T cell differentiation
GO:0048872 homeostasis of number of cells
GO:0050862 positive regulation of T cell receptor signaling pathway
GO:0070266 necroptotic process
GO:0070423 nucleotide-binding oligomerization domain containing signaling pathway
GO:0070507 regulation of microtubule cytoskeleton organization
GO:0070536 protein K63-linked deubiquitination
GO:0071108 protein K48-linked deubiquitination
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:1901026 ripoptosome assembly involved in necroptotic process
GO:1901223 negative regulation of NIK/NF-kappaB signaling
GO:1902017 regulation of cilium assembly
GO:1903829 positive regulation of cellular protein localization
GO:1990108 protein linear deubiquitination
GO:2001238 positive regulation of extrinsic apoptotic signaling pathway
GO:2001242 regulation of intrinsic apoptotic signaling pathway
GO:0002181 cytoplasmic translation

Cellular Component:
GO:0005737 cytoplasm
GO:0005813 centrosome
GO:0005815 microtubule organizing center
GO:0005819 spindle
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005874 microtubule
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0031234 extrinsic component of cytoplasmic side of plasma membrane
GO:0036064 ciliary basal body
GO:0042995 cell projection
GO:0048471 perinuclear region of cytoplasm
GO:0097542 ciliary tip
GO:0005881 cytoplasmic microtubule
GO:0030496 midbody


-  Descriptions from all associated GenBank mRNAs
  LF213752 - JP 2014500723-A/21255: Polycomb-Associated Non-Coding RNAs.
LF208211 - JP 2014500723-A/15714: Polycomb-Associated Non-Coding RNAs.
AK292975 - Homo sapiens cDNA FLJ78684 complete cds, highly similar to Homo sapiens cylindromatosis (turban tumor syndrome), mRNA.
AK225202 - Homo sapiens mRNA for Splice isoform 2 of Q9NQC7 variant, clone: COL04245.
AJ250014 - Homo sapiens mRNA for Familial Cylindromatosis cyld gene.
AK310832 - Homo sapiens cDNA, FLJ17874.
AK056226 - Homo sapiens cDNA FLJ31664 fis, clone NT2RI2004535, highly similar to Homo sapiens mRNA for Familial Cylindromatosis cyld gene.
AF161542 - Homo sapiens HSPC057 mRNA, complete cds.
BC012342 - Homo sapiens cylindromatosis (turban tumor syndrome), mRNA (cDNA clone MGC:19923 IMAGE:4552767), complete cds.
AB020656 - Homo sapiens KIAA0849 mRNA for KIAA0849 protein.
AB384014 - Synthetic construct DNA, clone: pF1KSDA0849, Homo sapiens CYLD gene for ubiquitin carboxyl-terminal hydrolase CYLD, complete cds, without stop codon, in Flexi system.
AK024348 - Homo sapiens cDNA FLJ14286 fis, clone PLACE1006129, highly similar to Probable ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.1.2.15).
AK024212 - Homo sapiens cDNA FLJ14150 fis, clone MAMMA1003026, highly similar to Probable ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.1.2.15).
LF373510 - JP 2014500723-A/181013: Polycomb-Associated Non-Coding RNAs.
LF373511 - JP 2014500723-A/181014: Polycomb-Associated Non-Coding RNAs.
LF373512 - JP 2014500723-A/181015: Polycomb-Associated Non-Coding RNAs.
LF373514 - JP 2014500723-A/181017: Polycomb-Associated Non-Coding RNAs.
AK000187 - Homo sapiens cDNA FLJ20180 fis, clone COL10238, highly similar to AB020656 Homo sapiens mRNA for KIAA0849 protein.
LF373515 - JP 2014500723-A/181018: Polycomb-Associated Non-Coding RNAs.
LF373517 - JP 2014500723-A/181020: Polycomb-Associated Non-Coding RNAs.
FN823255 - Homo sapiens partial mRNA for CYLD protein, variant 5.
FN823256 - Homo sapiens partial mRNA for CYLD protein, variant 8.
LF373520 - JP 2014500723-A/181023: Polycomb-Associated Non-Coding RNAs.
JD492926 - Sequence 473950 from Patent EP1572962.
JD466044 - Sequence 447068 from Patent EP1572962.
JD521418 - Sequence 502442 from Patent EP1572962.
JD047374 - Sequence 28398 from Patent EP1572962.
JD403839 - Sequence 384863 from Patent EP1572962.
JD268630 - Sequence 249654 from Patent EP1572962.
LF373521 - JP 2014500723-A/181024: Polycomb-Associated Non-Coding RNAs.
JD020367 - Sequence 1391 from Patent EP1572962.
JD030227 - Sequence 11251 from Patent EP1572962.
JD545593 - Sequence 526617 from Patent EP1572962.
JD248903 - Sequence 229927 from Patent EP1572962.
JD433019 - Sequence 414043 from Patent EP1572962.
JD504207 - Sequence 485231 from Patent EP1572962.
JD359764 - Sequence 340788 from Patent EP1572962.
JD312273 - Sequence 293297 from Patent EP1572962.
JD182797 - Sequence 163821 from Patent EP1572962.
JD087653 - Sequence 68677 from Patent EP1572962.
JD260156 - Sequence 241180 from Patent EP1572962.
JD089144 - Sequence 70168 from Patent EP1572962.
JD305913 - Sequence 286937 from Patent EP1572962.
AL050166 - Homo sapiens mRNA; cDNA DKFZp586D1122 (from clone DKFZp586D1122).
LF373522 - JP 2014500723-A/181025: Polycomb-Associated Non-Coding RNAs.
LF373523 - JP 2014500723-A/181026: Polycomb-Associated Non-Coding RNAs.
JD019154 - Sequence 178 from Patent EP1572962.
JD032064 - Sequence 13088 from Patent EP1572962.
LF373524 - JP 2014500723-A/181027: Polycomb-Associated Non-Coding RNAs.
MA609087 - JP 2018138019-A/181013: Polycomb-Associated Non-Coding RNAs.
MA609088 - JP 2018138019-A/181014: Polycomb-Associated Non-Coding RNAs.
MA609089 - JP 2018138019-A/181015: Polycomb-Associated Non-Coding RNAs.
MA609091 - JP 2018138019-A/181017: Polycomb-Associated Non-Coding RNAs.
MA609092 - JP 2018138019-A/181018: Polycomb-Associated Non-Coding RNAs.
MA609094 - JP 2018138019-A/181020: Polycomb-Associated Non-Coding RNAs.
MA609097 - JP 2018138019-A/181023: Polycomb-Associated Non-Coding RNAs.
MA609098 - JP 2018138019-A/181024: Polycomb-Associated Non-Coding RNAs.
MA609099 - JP 2018138019-A/181025: Polycomb-Associated Non-Coding RNAs.
MA609100 - JP 2018138019-A/181026: Polycomb-Associated Non-Coding RNAs.
MA609101 - JP 2018138019-A/181027: Polycomb-Associated Non-Coding RNAs.
MA449329 - JP 2018138019-A/21255: Polycomb-Associated Non-Coding RNAs.
MA443788 - JP 2018138019-A/15714: Polycomb-Associated Non-Coding RNAs.

-  Biochemical and Signaling Pathways
  Reactome (by CSHL, EBI, and GO)

Protein Q9NQC7 (Reactome details) participates in the following event(s):

R-HSA-5357831 CYLD is phosphorylated by IKK
R-HSA-5357928 CLIP3 and CYLD bind TNF signaling complex
R-HSA-5696627 CYLD deubiquitinates K63polyUb-TRAF2,K63polyUb-TRAF6,K63polyUb-RIPK1,K63polyUb-IKBKG
R-HSA-741411 CYLD deubiquitinates NEMO
R-HSA-5357905 Regulation of TNFR1 signaling
R-HSA-5689880 Ub-specific processing proteases
R-HSA-75893 TNF signaling
R-HSA-168638 NOD1/2 Signaling Pathway
R-HSA-936440 Negative regulators of DDX58/IFIH1 signaling
R-HSA-5688426 Deubiquitination
R-HSA-73887 Death Receptor Signalling
R-HSA-168643 Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
R-HSA-168928 DDX58/IFIH1-mediated induction of interferon-alpha/beta
R-HSA-597592 Post-translational protein modification
R-HSA-162582 Signal Transduction
R-HSA-168249 Innate Immune System
R-HSA-392499 Metabolism of proteins
R-HSA-168256 Immune System

-  Other Names for This Gene
  Alternate Gene Symbols: CYLD , CYLD1, CYLD_HUMAN, ENST00000427738.1, ENST00000427738.2, ENST00000427738.3, ENST00000427738.4, ENST00000427738.5, ENST00000427738.6, ENST00000427738.7, HSPC057, KIAA0849 , NM_001378743, O94934, Q7L3N6, Q96EH0, Q9NQC7, Q9NZX9, uc319wtv.1, uc319wtv.2
UCSC ID: ENST00000427738.8_8
RefSeq Accession: NM_001378743.1
Protein: Q9NQC7 (aka CYLD_HUMAN)

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene CYLD:
cyld-cs (CYLD Cutaneous Syndrome)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.